Primary radical surgery or preoperative drainage? A clinical decision framework for pediatric choledochal cysts

Zhenhua Yang1, Peng Wu1, Jun Zhou1

  • 1Department of General Surgery, Children's Hospital of Nanjing Medical University, Nanjing, China.

Insights

A new risk score helps predict poor outcomes in children with complicated choledochal cysts (CDC) undergoing surgery. This tool aids in choosing between primary radical surgery and preoperative drainage, improving patient stratification.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Surgical Risk Assessment

Background:

  • The management of complicated choledochal cysts (CDC) in children often involves subjective decisions between primary radical surgery (PRS) and preoperative drainage (PD).
  • Objective preoperative risk stratification is needed to guide treatment choices for pediatric CDC patients.

Purpose of the Study:

  • To develop and validate an objective preoperative risk framework for children with complicated choledochal cysts.
  • To identify key predictors of severe complications and surgical difficulty in pediatric CDC patients.

Main Methods:

  • A retrospective review of 454 pediatric patients with CDCs was conducted.
  • Logistic regression was used to build a prediction model for severe complications (Clavien-Dindo ≥II).
  • A simplified 11-point risk score was derived from a composite outcome analysis including inflammation score, intrahepatic duct dilatation, and hemoglobin.

Main Results:

  • Severe complications occurred in 6.3% of PRS patients.
  • Intrahepatic duct dilatation and an inflammation score ≥2 were significant predictors of severe complications.
  • The 11-point risk score stratified patients into low (5.5%), medium (13.6%), and high-risk (18.3%) groups for poor outcomes.

Conclusions:

  • A preliminary preoperative risk score utilizing three variables can identify children at higher risk of adverse outcomes following primary radical surgery for choledochal cysts.
  • This risk assessment tool requires external validation and should complement, not replace, clinical judgment in treatment decisions.
Abstract